SPONSOR
Denali Therapeutics Inc.
Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 3, Phase 2
NCT05371613 Phase 2, Phase 3
Recruiting
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
Mucopolysaccharidosis II
NCT06602193 Phase 2
Recruiting
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)
Parkinson Disease